Literature DB >> 21791665

Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.

Ronen Ben-Ami1, Guillermo Garcia-Effron, Russell E Lewis, Soledad Gamarra, Konstantinos Leventakos, David S Perlin, Dimitrios P Kontoyiannis.   

Abstract

The identification of FKS1 mutations in Candida albicans associated with echinocandin resistance has raised concerns over the spread of drug-resistant strains. We studied the impact of fks1 mutations on C. albicans virulence and fitness. Compared with wild-type strains for FKS1, echinocandin-resistant C. albicans strains with homozygous fks1 hot-spot mutations had reduced maximum catalytic capacity of their glucan synthase complexes and thicker cell walls attributable to increased cell wall chitin content. The fks1 mutants with the highest chitin contents had reduced growth rates and impaired filamentation capacities. Fks1 mutants were hypovirulent in fly and mouse models of candidiasis, and this phenotype correlated with the cell wall chitin content. In addition, we observed reduced fitness of echinocandin-resistant C. albicans in competitive mixed infection models. We conclude that fks1 mutations that confer echinocandin resistance come at fitness and virulence costs, which may limit their epidemiological and clinical impact.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791665      PMCID: PMC3144175          DOI: 10.1093/infdis/jir351

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  36 in total

1.  Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin.

Authors:  David A Stevens; Masayuki Ichinomiya; Yukako Koshi; Hiroyuki Horiuchi
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1.

Authors:  Sergey V Balashov; Steven Park; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Fungal LysM effectors: extinguishers of host immunity?

Authors:  Ronnie de Jonge; Bart P H J Thomma
Journal:  Trends Microbiol       Date:  2009-03-18       Impact factor: 17.079

4.  Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility.

Authors:  Santosh Katiyar; Michael Pfaller; Thomas Edlind
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

5.  Progressive esophagitis caused by Candida albicans with reduced susceptibility to caspofungin.

Authors:  Christopher D Miller; Ben W Lomaestro; Steven Park; David S Perlin
Journal:  Pharmacotherapy       Date:  2006-06       Impact factor: 4.705

6.  Chitin is a size-dependent regulator of macrophage TNF and IL-10 production.

Authors:  Carla A Da Silva; Cécile Chalouni; Adam Williams; Dominik Hartl; Chun G Lee; Jack A Elias
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

7.  Antifungal activity of colistin against mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection.

Authors:  Ronen Ben-Ami; Russell E Lewis; Jeffrey Tarrand; Konstantinos Leventakos; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2009-10-26       Impact factor: 5.191

8.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David Andes; Daniel K Benjamin; Thierry F Calandra; John E Edwards; Scott G Filler; John F Fisher; Bart-Jan Kullberg; Luis Ostrosky-Zeichner; Annette C Reboli; John H Rex; Thomas J Walsh; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

9.  The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans.

Authors:  Carol A Munro; Serena Selvaggini; Irene de Bruijn; Louise Walker; Megan D Lenardon; Bertus Gerssen; Sarah Milne; Alistair J P Brown; Neil A R Gow
Journal:  Mol Microbiol       Date:  2007-03       Impact factor: 3.501

10.  Functional analysis of Candida albicans GPI-anchored proteins: roles in cell wall integrity and caspofungin sensitivity.

Authors:  Armêl Plaine; Louise Walker; Gregory Da Costa; Héctor M Mora-Montes; Alastair McKinnon; Neil A R Gow; Claude Gaillardin; Carol A Munro; Mathias L Richard
Journal:  Fungal Genet Biol       Date:  2008-08-15       Impact factor: 3.495

View more
  55 in total

Review 1.  Mechanisms of Antifungal Drug Resistance.

Authors:  Leah E Cowen; Dominique Sanglard; Susan J Howard; P David Rogers; David S Perlin
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

2.  Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis.

Authors:  Rasmus Hare Jensen; Helle Krogh Johansen; Maiken Cavling Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2012-10-22       Impact factor: 5.191

3.  Pre-exposure of Candida species to cytarabine and daunorubicin does not affect their in vitro antifungal susceptibility and virulence in flies.

Authors:  Régis A Zanette; Dimitrios P Kontoyiannis
Journal:  Virulence       Date:  2013-04-23       Impact factor: 5.882

4.  Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.

Authors:  Keunsook K Lee; Donna M Maccallum; Mette D Jacobsen; Louise A Walker; Frank C Odds; Neil A R Gow; Carol A Munro
Journal:  Antimicrob Agents Chemother       Date:  2011-10-10       Impact factor: 5.191

5.  Dose escalation studies with caspofungin against Candida glabrata.

Authors:  Marianna Domán; Renátó Kovács; David S Perlin; Gábor Kardos; Rudolf Gesztelyi; Béla Juhász; Aliz Bozó; László Majoros
Journal:  J Med Microbiol       Date:  2015-06-30       Impact factor: 2.472

6.  Integrin-based diffusion barrier separates membrane domains enabling the formation of microbiostatic frustrated phagosomes.

Authors:  Michelle E Maxson; Xenia Naj; Teresa R O'Meara; Jonathan D Plumb; Leah E Cowen; Sergio Grinstein
Journal:  Elife       Date:  2018-03-19       Impact factor: 8.140

7.  Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates.

Authors:  Nicholas D Beyda; Guangling Liao; Bradley T Endres; Russell E Lewis; Kevin W Garey
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

8.  A competitive infection model of hematogenously disseminated candidiasis in mice redefines the role of Candida albicans IRS4 in pathogenesis.

Authors:  Suresh B Raman; M Hong Nguyen; Shaoji Cheng; Hassan Badrane; Kenneth A Iczkowski; Marilyn Wegener; Sarah L Gaffen; Aaron P Mitchell; Cornelius J Clancy
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

9.  CRS-MIS in Candida glabrata: sphingolipids modulate echinocandin-Fks interaction.

Authors:  Kelley R Healey; Santosh K Katiyar; Shriya Raj; Thomas D Edlind
Journal:  Mol Microbiol       Date:  2012-08-22       Impact factor: 3.501

10.  Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.

Authors:  Barbara D Alexander; Melissa D Johnson; Christopher D Pfeiffer; Cristina Jiménez-Ortigosa; Jelena Catania; Rachel Booker; Mariana Castanheira; Shawn A Messer; David S Perlin; Michael A Pfaller
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.